Previous 10 | Next 10 |
Although the Healthcare sector is having a positive year in absolute terms, that isn't the case in relative terms. Biotech stocks are having a difficult year, in spite of many of those trading at dirt-cheap valuations that don't even reflect the cash they have in-hand. It's very l...
MENLO PARK, Calif. and SINGAPORE, Dec. 06, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the appointment of IQVIA Biotech, a l...
Dan Loeb's 13F portfolio value increased from $17.08B to $18.32B this quarter. The number of positions decreased from 126 to 113. Third Point increased Amazon while decreasing Intel and dropping JD.com, SoFi Technologies, and Uber Technologies during the quarter. The top three pos...
IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, is launching new Research Nursing and Phlebotomy services. These new services offer patients participating in clinical trials access to ...
IQVIA recognized in IDC MarketScape™ for its data and analytics capabilities and growing suite of software platforms IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, was ...
IQVIA Holdings Inc. (NYSE:IQV) traded at a new 52-week high today of $272.25. So far today approximately 222,000 shares have been exchanged, as compared to an average 30-day volume of 747,000 shares. IQVIA Holdings Inc. (NYSE:IQV) is currently priced 64.1% above its average consensus ana...
IQVIA (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the launch of Grants and Funding Management, new module within the Orchestrated Customer Engagement (OCE) solutions portfoli...
IQVIA Holdings (IQV +6.0%) has recorded the best intraday gain in over a year to reach a 52-week high after the company highlighted its prospects at the 2021 Analyst and Investor Conference today. Evercore ISI has welcomed the short-term goals unveiled at the event. For 2022, IQVIA (NYSE:IQV)...
William von Mueffling's 13F portfolio value decreased this quarter from $14.85B to $14.67B. Cantillon increased Brunswick Corp while dropping Nielsen Holdings. The portfolio continues to be very concentrated with the top five positions accounting for ~26% of the 13F portfolio. ...
Image source: The Motley Fool. IQVIA Holdings inc (NYSE: IQV) Q3 2021 Earnings Call Oct 21, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: IQVIA Holdings inc (IQV) Q3 2021 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...